Home

Jeffrey Alan Wolf

CIK 1381450 · Chief Executive Officer · last filed 2026-01-06

Jeffrey Alan Wolf is a Chief Executive Officer who has filed 37 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TOVX, was dated Jan 6, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

37

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TOVX Director — $0.24 — $0 4 2026-01-06
Scorpius Holdings, Inc. (SCPX) Delisted Chief Executive Officer 17,919 $0.00 $25 $0 1 2024-05-17
Scorpius Holdings, Inc. (NHWK) Delisted Chief Executive Officer — $0.41 — $0 1 2022-12-09
Scorpius Holdings, Inc. (HTBX) Delisted Chief Executive Officer 1,083,020 $2.38 $2.58M $0 16 2022-01-03
Theriva Biologics, Inc. (SYN) Delisted Director 10,842 $1.02 $11.1K $0 10 2021-12-27
Theriva Biologics, Inc. (AEN) Delisted Director — — — $0 3 2011-01-07
Theriva Biologics, Inc. (PP) Delisted Director — $26.10 — $0 1 2007-11-06

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-06 TOVX Grant (A) — $0 EDGAR
2025-05-01 TOVX Grant (A) — $0 EDGAR
2024-05-17 Scorpius Holdings, Inc. (SCPX) Delisted Grant (A) +2,500,000 $0 EDGAR
2023-12-15 TOVX Grant (A) — $0 EDGAR
2022-12-16 TOVX Grant (A) — $0 EDGAR
2022-12-09 Scorpius Holdings, Inc. (NHWK) Delisted Grant (A) — $0 EDGAR
2022-01-03 Scorpius Holdings, Inc. (HTBX) Delisted Mixed — $0 EDGAR
2021-12-27 Theriva Biologics, Inc. (SYN) Delisted Grant (A) — $0 EDGAR
2021-12-15 Scorpius Holdings, Inc. (HTBX) Delisted Grant (A) +246,305 $0 EDGAR
2021-01-06 Scorpius Holdings, Inc. (HTBX) Delisted Grant (A) +288,100 $0 EDGAR
Showing 1–10 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.